Intercell completes debt financing

Intercell AG (VSE:ICLL; OTCQX: INRLY), Vienna, Austria Business: Infectious Date completed: 5/14/12 Type: Debt financing Raised: €20 million ($25.8 million) Investor: BB Biotech Note: The six-year sec...